Managing T-cell lymphoma treatment side effects: when to seek help and what to record at home

The first question after a new symptom is often whether it is a normal side effect. A more useful question is whether it needs assessment today and which service can provide that assessment. Risk depends on the medicines used, current blood counts, transplant history and the stage of treatment. An uncomplicated previous cycle does not guarantee that the next one will follow the same pattern. Ask the team to write down daytime and overnight contact numbers, its fever instructions and the symptoms that should lead directly to emergency care.

Key takeaways

These excerpts come from the original article. Read the full sections below for context.

Treatment can reduce neutrophils and make infection more dangerous. Follow the temperature threshold supplied by the treating team. Shaking chills, substantial breathlessness, confusion or rapidly worsening weakness also warrant immediate contact or emergency assessment. A high temperature is not required for a serious infection, particularly with corticosteroid use or substantial immunosuppression. Do not delay seeking advice while testing whether an antipyretic can bring the temperature down; these medicines can conceal a useful warning sign. NCI: Infection and Neutropenia during Cancer Treatment
An antiemetic plan may include medicines taken before treatment and additional instructions for symptoms that break through later. Confirm which medicine serves each purpose and whom to contact if it fails. Record when vomiting starts, how often it occurs, whether fluids remain down and which prescribed medicines have already been taken. Persistent vomiting, clearly reduced urine or dizziness on standing should prompt reassessment for dehydration and electrolyte disturbance. Doubling a previous prescription without advice may introduce another problem. NCI: Nausea and Vomiting during Cancer Treatment
A one-page record can include symptom onset and resolution, temperatures, food and fluid intake, bowel changes, the effect of pain or numbness on daily tasks, and the response to telephone advice. Paper is sufficient. Linking entries to treatment dates helps identify delayed reactions and problems that accumulate over successive cycles. It also reduces the chance that a significant episode will be forgotten once the patient feels better at the next appointment.

Quick answer

Full guide

Leave the treatment unit with a practical contact plan

Keep this information beside a current medication list. Include anticancer medicines, corticosteroids, infection prophylaxis, antiemetics, vitamins, pain medicines and products bought without a prescription. A photograph helps a relative find the list quickly, but retain the prescriptions and dates of recent treatment as well. Telling an emergency clinician only that chemotherapy was given may leave out an antibody, a targeted drug or a transplant exposure that changes the possible causes of illness.

Fever and shaking chills require prompt action

Treatment can reduce neutrophils and make infection more dangerous. Follow the temperature threshold supplied by the treating team. Shaking chills, substantial breathlessness, confusion or rapidly worsening weakness also warrant immediate contact or emergency assessment. A high temperature is not required for a serious infection, particularly with corticosteroid use or substantial immunosuppression. Do not delay seeking advice while testing whether an antipyretic can bring the temperature down; these medicines can conceal a useful warning sign. NCI: Infection and Neutropenia during Cancer Treatment

Leftover antibiotics are not a substitute for assessment. Blood counts, the suspected site of infection, cultures and recent antimicrobial exposure may all influence the treatment chosen. Unplanned antibiotics can complicate interpretation. Tell the receiving service about an implanted port or other catheter, the latest neutrophil result if available, and any antibiotic allergy. Someone who is confused, unable to stand safely or struggling to breathe should use local emergency services rather than drive to hospital alone.

Certain drugs require a more specific prevention plan. China's current national guidance for golidocitinib calls for Pneumocystis jirovecii pneumonia prophylaxis and highlights infection and viral reactivation risks. The prescribing service should explain when the preventive medicine starts, how missed doses are handled and who decides when it can stop. New eye pain, increasing floaters or deteriorating vision also need timely reporting, because potentially important eye complications should not be dismissed as treatment fatigue. 中国国家卫生健康委：《新型抗肿瘤药物临床应用指导原则（2025年版）》，2026-01-26发布

Bleeding needs context as well as a platelet count

New extensive bruising, pinpoint red spots or bleeding from the gums or nose can be associated with a low platelet count, although other causes are possible. Persistent bleeding, black stools, vomiting blood, or bleeding concerns accompanied by severe headache or altered awareness need urgent evaluation. A single laboratory number cannot tell a patient whether it is safe to wait at home. Clinicians consider the bleeding itself, the platelet count, accompanying illness and other medicines. NCI: Bleeding and Bruising during Cancer Treatment

Reduce opportunities for falls and cuts, and ask the nurse about oral care and pressure after blood sampling. Report aspirin, ibuprofen, anticoagulants and herbal products. A patient prescribed an anticoagulant for a heart or clotting condition should not independently stop it because bruising has appeared: both continuing and interrupting it may carry risks. The relevant clinicians need to agree on the response. A soft toothbrush can help reduce local trauma, but daily care should still be adapted to current mouth symptoms and blood counts.

Report altered sensation before it limits walking

Vincristine-containing regimens and brentuximab vedotin can cause peripheral nerve problems. Difficulty fastening buttons, a sensation of walking on padding, dropping objects, burning pain or tingling are worth mentioning early. Do not assume these symptoms must be tolerated because the lymphoma is shrinking. The team may examine sensation, strength and balance and ask how daily activities have changed before deciding whether treatment modification is appropriate. NCI: Nerve Problems and Cancer Treatment ADCETRIS: current US prescribing information, Pfizer

At home, clear obstacles from walkways and improve lighting for night-time trips to the bathroom. Reduced sensation can make hot water dangerous, so ask another person to check its temperature when necessary. New marked weakness, inability to walk safely or urinary difficulties deserve prompt assessment rather than being labelled routine numbness. Diabetes, nutritional problems and pre-existing nerve disease may also contribute. A description of when symptoms began, which areas are affected and how quickly they are progressing is more useful than saying that treatment is producing severe side effects.

Mouth pain can disrupt hydration and essential medicines

Oral soreness matters beyond its effect on meals. Contact the service if pain prevents drinking or swallowing prescribed medicines, or if fever, new white patches or other concerning changes develop. Ask which mouth-cleaning and rinsing methods are appropriate. Soft food at a comfortable temperature may be easier to manage, whereas repeated use of irritating products can make care more difficult. Dental extractions and other invasive dental work should be coordinated with the oncology team, particularly when blood counts are low. NCI: Mouth and Throat Problems during Cancer Treatment

Pralatrexate prescribing information specifically requires folic acid and vitamin B12 support and monitoring for mucositis, cytopenias and renal problems. Those measures belong to the treatment prescription; an arbitrary multivitamin is not an equivalent replacement. If mouth pain becomes substantially worse after a dose, report it before the next scheduled administration so the clinician can assess whether treatment should be withheld or changed. The overseas label is used here to explain a drug-specific safety issue, not to establish a Chinese indication or local supply. DailyMed: FOLOTYN pralatrexate prescribing information

Separate nausea prevention from rescue treatment

An antiemetic plan may include medicines taken before treatment and additional instructions for symptoms that break through later. Confirm which medicine serves each purpose and whom to contact if it fails. Record when vomiting starts, how often it occurs, whether fluids remain down and which prescribed medicines have already been taken. Persistent vomiting, clearly reduced urine or dizziness on standing should prompt reassessment for dehydration and electrolyte disturbance. Doubling a previous prescription without advice may introduce another problem. NCI: Nausea and Vomiting during Cancer Treatment

The diary can reveal delayed symptoms that are absent during the infusion visit. It also helps the team distinguish nausea from pain, constipation, infection or another contributor to poor intake. Families can offer small, tolerable amounts of fluid and food within the agreed plan, but a patient who cannot retain fluids needs clinical guidance rather than pressure to finish a meal. The purpose of recording intake is to inform care, not to grade the patient's effort.

Diarrhea should not automatically be blamed on food

Loose stools may reflect medication, infection or intestinal disease. After transplantation, graft-versus-host disease may also enter the assessment. Note stool frequency and appearance, blood, abdominal pain, fever and the ability to drink. Bloody stool, marked abdominal swelling or pain, and inability to replace fluids are reasons for prompt evaluation. Suppressing symptoms with an over-the-counter antidiarrheal is not an adequate response to unexplained diarrhea accompanied by fever or blood. NCI: Diarrhea and Cancer Treatment

The clinician may need a stool sample, blood tests or a review of recent antibiotics and travel. Tell the team about laxatives, supplements and changes in food intake as well as anticancer drugs. It is helpful to describe a change from the person's usual bowel pattern, because a simple count does not convey the same degree of illness for everyone. Do not infer that improvement after one dose of a symptom medicine proves the underlying cause has been addressed.

A new rash may require examination or a biopsy

For people with cutaneous T-cell lymphoma, a drug rash, infection and lymphoma-related skin change can look similar. Mogamulizumab prescribing information warns about serious skin reactions. A rapidly spreading eruption, blisters, peeling skin or involvement of the eyes or mouth requires timely assessment. Photographs help show the course of a rash, but cannot replace examination; in some cases a skin biopsy is needed to guide the next step. DailyMed: POTELIGEO mogamulizumab prescribing information, February 2026

Describe new creams, antibiotics and other medicines rather than focusing exclusively on the cancer treatment. If allogeneic transplantation is considered later, supply the full mogamulizumab exposure history because the label also identifies important subsequent transplant risks. A symptom disappearing after treatment interruption is information for the team, but patients should not independently restart a medicine after a potentially serious reaction. The restart decision depends on the likely cause and the severity of the event.

Fatigue is a functional problem that deserves assessment

Fatigue can arise from treatment, anemia, disturbed sleep, pain, inadequate intake and emotional distress, sometimes in combination. Explain what has become difficult: walking to the bathroom, showering, preparing food or remaining awake for conversation. Also say whether rest provides relief. These descriptions help the clinician understand a change in function that a single numerical fatigue score may miss. Breaking activities into shorter periods and scheduling rest can be useful, but exercise advice must account for infection, anemia, platelet count and falls risk. NCI: Fatigue and Cancer

Sudden deterioration with chest pain, breathlessness, fainting or new palpitations should first be assessed for an acute cause. Buying more supplements may produce drug interactions and delay that assessment. When appetite is poor, a nutrition professional can help identify tolerable food and fluid options and consider additional support. Maintaining safe intake and useful strength is the aim; forcing a fixed amount of food can add conflict without resolving the cause of reduced eating. NCI PDQ: Nutrition in Cancer Care

Make the interval between visits visible to the team

A one-page record can include symptom onset and resolution, temperatures, food and fluid intake, bowel changes, the effect of pain or numbness on daily tasks, and the response to telephone advice. Paper is sufficient. Linking entries to treatment dates helps identify delayed reactions and problems that accumulate over successive cycles. It also reduces the chance that a significant episode will be forgotten once the patient feels better at the next appointment.

Do not conceal symptoms to protect the next treatment date. A delay, dose adjustment or additional supportive medicine may be intended to make continued therapy safer. Ask the clinician what finding would permit treatment to resume and how it will be checked. This gives a practical next step while preserving the distinction between a safety adjustment and a judgement about lymphoma control.

Before travelling home, obtain the latest blood count, kidney and liver results, last treatment date and any special prophylaxis instructions. Identify where urgent laboratory testing, catheter care and transfusion assessment can be arranged. Relatives can share responsibility for the medication list and emergency calls, especially when the patient is exhausted. The goal is a dependable route to help and an accurate account of what happened between clinic visits, rather than expecting the patient to diagnose each complication alone.